Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PDE9A | O76083 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | FABP4 | P15090 | 1/20 | 0.47 |
| ▸ | TYMS | P04818 | 2/20 | 0.46 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18251 | 0.80 | PNP (0.62) | PNPXDH | |
| SCHEMBL2623146 | 0.79 | ALDH1A1 (0.54) | L3MBTL1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1394088 | 0.78 | PNP (0.61) | PNPXDH | |
| SCHEMBL2623144 | 0.78 | TK1 (0.47) | PIM1 | |
| SCHEMBL10047094 | 0.78 | XDH (0.40) | PNPLMNAXDH | |
| SCHEMBL5062459 | 0.78 | XDH (0.46) | PNPMEN1POLBHTTKMT2A | |
| Cyanide SCHEMBL2694132 | 0.76 | PNP (0.58) | PNPLMNAXDHTSHR | |
| SCHEMBL7658491 | 0.76 | KDM4E (0.44) | PNPMEN1KMT2A | |
| SCHEMBL28472801 | 0.76 | ROCK2 (0.47) | L3MBTL1MEN1POLBKMT2ASMN1; SMN2 | |
| SCHEMBL21183279 | 0.75 | XDH (0.44) | PKMPIM1PNPLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| EP-4684872-A1 | DEVICE AND METHOD FOR WATER-IN-AIR GENERATION OF DROPLETS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-01-28 | — | — | EP | claimed |
| CN-117835992-A | Method for activating T cells | PACT制药公司 | 2024-04-05 | — | — | CN | claimed |
| US-20240100096-A1 | METHODS OF ACTIVATING T CELLS | ADOC SSF, LLC (US) | 2024-03-28 | — | — | US | claimed |
| US-20230181466-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-06-15 | — | — | US | claimed |
| US-20230038598-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-02-09 | — | — | US | claimed |
| CN-115379829-A | Synthesizing extracellular vesicles by bottom-up assembly | 马克斯·普朗克科学促进学会 | 2022-11-22 | — | — | CN | claimed |
| CN-115087434-A | Microfluidic production of bio-functionalized giant unilamellar vesicles for targeted cargo delivery | 马克斯·普朗克科学促进学会 | 2022-09-20 | — | — | CN | claimed |
| EP-4054532-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-09-14 | — | — | EP | claimed |
| EP-4054533-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-09-14 | — | — | EP | claimed |
| WO-2021152115-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-08-05 | — | — | WO | claimed |
| EP-3858332-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-08-04 | — | — | EP | claimed |
| WO-2021123399-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-06-24 | — | — | WO | claimed |
| EP-3838266-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED INTRACELLULAR CARGO DELIVERY | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-06-23 | — | — | EP | claimed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-4684872-A1 | DEVICE AND METHOD FOR WATER-IN-AIR GENERATION OF DROPLETS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4619524-A1 | METHODS AND COMPOSITIONS FOR PREVENTING, TREATING, OR REVERSING CARDIAC DIASTOLIC DYSFUNCTION | Genkardia Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-20110262661-A1 | Optical performance humidity dependency improving agent for cellulose acylate film | FUJIFILM CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110076423-A1 | CELLULOSE ACYLATE FILM, RETARDATION FILM, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110076423-A1 | CELLULOSE ACYLATE FILM, RETARDATION FILM, POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230038598-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | PCNA, BOD1L1, SARS1 | HPGD 3901/4885PKM 3244/4885L3MBTL1 113/4885 |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | HPGD 4685/4885PKM 3200/4885L3MBTL1 3656/4885 |
| US-20110262661-A1 | Optical performance humidity dependency improving agent for cellulose acylate film | ALKBH1, ACOT7, ALKBH2 | HPGD 3788/4885PKM 3902/4885L3MBTL1 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.